Clinical Trial Update: Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of Granulocyte Colony-Stimulating Factor, Bortezomib, Cyclophosphamide, and Dexamethasone in patients with multiple myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Myeloma, Bortezomib | Phase 2 | Status: UNKNOWN